Patient Education
Listed below are useful resources to assist your patients.
Patient Brochures
This booklet helps patients understand what they can expect from CTCL treatment with ZOLINZA and how they can care for themselves.
This booklet provides disease- and treatment-related support for the CTCL patient receiving treatment with ZOLINZA.
This is a booklet with information about living with CTCL, suggestions for dealing with treatment side effects, and places to go for support.
This is a brief guide to types of CTCL treatments, along with a treatment tracker.
This booklet helps answer patients' questions about CTCL and gives them tips for working with their healthcare team.
Back to Top
Educational and Emotional Support
Back to Top
Selected Important Safety Information
- Pulmonary embolism and deep vein thrombosis have been reported. Monitor patients for pertinent signs and symptoms, particularly in patients with a history of thromboembolic events.
- Treatment with ZOLINZA can cause dose-related thrombocytopenia and anemia. If platelet counts and/or hemoglobin are reduced during treatment, modify the dose or discontinue therapy.
Before prescribing ZOLINZA, please read the physician Prescribing Information. The Patient Product Information is also available.
Back to Top
![Zolinza® [vorinostat] capsules Reactivate Expression](http://a248.e.akamai.net/7/248/430/20080731143858/www.zolinza.com/zolinza/shared/images/Logo_zolinza.gif){kind=logo}
